Abstract
Transmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors as well as the ligand affinity.
Here, we describe a classic method in which cells or tissue membranes are exposed to radiolabeled molecules (radioligands) that bind selectively to the receptors in the sample (receptor binding assay). Similarly, the functional consequence of the receptor occupancy or level of G protein activation can be measured by [35S]GTPγS binding assay, also known as functional binding. This assay measures the binding of the nonhydrolyzable analog [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits.
The above radiometric assays are useful to determine the affinity and receptor density of a drug, and to differentiate among agonist, antagonist, and inverse agonist activities, the traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Yamamura HI, Enna SJ (1990) Kuhar MJ (1990) methods in neurotransmitter receptor analysis. Raven Press, Nueva York
Selley DE, Stark S, Sim LJ, Childers SR (1996) Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranes. Life Sci 59:659–668. https://doi.org/10.1016/0024-3205(96)00347-5
Harrison C, Traynor JR (2003) The 35S GTP-gamma-S binding assay: approaches and applications in pharmacology. Life Sci 74:489–508. https://doi.org/10.1016/j.lfs.2003.07.005
Snyder SH, JPJr B (1976) Neurotransmitter receptors in the brain: biochemical identification. Annu Rev Physiol 38:153–175. https://doi.org/10.1146/annurev.ph.38.030176.001101
Kenakin TP (1997) Pharmacologic analysis of drug receptor interaction, 3rd edn. Lippincott-Raven, New York
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108. https://doi.org/10.1016/0006-2952(73)90196-2
Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for the characterization of ligand binding system. Anal Biochem 107:220–239. https://doi.org/10.1016/0003-2697(80)90515-1
Strange PG (2010) Use of the GTPγS ([35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors. Br J Pharmacol 161:1238–1249. https://doi.org/10.1111/j.1476-5381.2010.00963.x
Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, Collaborators CGTP (2019) THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors. Br J Pharmacol 176(S1):S21–S141. https://doi.org/10.1111/bph.14748
Alexander SPH, Mathie A, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, Collaborators CGTP (2019) THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: ion channels. Br J Pharmacol 176(S1):S142–S228. https://doi.org/10.1111/bph.14749
Alexander SPH, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Sharman JL, Southan C, Davies JA, Collaborators CGTP (2019) THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: transporters. Br J Pharmacol 176(S1):S397–S493. https://doi.org/10.1111/bph.14753
DeLapp NW (2004) The antibody-capture [(35)S]GTPgammaS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology. Trends Pharmacol Sci 25:400–401. https://doi.org/10.1016/j.tips.2004.06.003
Acknowledgments
This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2015-67457-R MINECO/FEDER) (MINECO/FEDER, UE), the Ministry of Science, Innovation and Universities (RTI2018-097534-B-I00) (MCIU/AEI/FEDER,UE), and the Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Pilar-Cuéllar, F., Garro-Martínez, E., Castro, E., Díaz, Á. (2021). Radioligand Binding Detection of Receptors in Brain Membranes. In: Lujan, R., Ciruela, F. (eds) Receptor and Ion Channel Detection in the Brain. Neuromethods, vol 169. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1522-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1522-5_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1521-8
Online ISBN: 978-1-0716-1522-5
eBook Packages: Springer Protocols